Overview

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Amphotericin B
Fluconazole
Liposomal amphotericin B
Voriconazole